Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: A population-based prospective serological study

Schizophrenia Research

Volumn 158, Issue 1-3, 2014, Pages 19-24

  Khandaker, Golam M ^a,b,c   Stochl, Jan ^a,b   Zammit, Stanley ^c,d   Lewis, Glyn ^c,e   Jones, Peter B ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ALSPAC birth cohort; Epstein Barr Virus; Herpes Simplex Virus; IgG antibody; IQ; Neurodevelopment; Psychotic experiences; Schizophrenia risk; Serology

Indexed keywords

VIRUS ANTIBODY; IMMUNOGLOBULIN G;

AGE; ANTIBODY BLOOD LEVEL; ANXIETY; ARTICLE; CHILD; CROWDING (AREA); DEPRESSION; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; FEMALE; GENDER; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; SOCIAL CLASS; ADOLESCENT; BLOOD; EPSTEIN-BARR VIRUS INFECTIONS; INTELLIGENCE; INTELLIGENCE TEST; ODDS RATIO; PRESCHOOL CHILD; PSYCHOLOGIC TEST; PSYCHOTIC DISORDERS; RISK; STATISTICAL MODEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTELLIGENCE; INTELLIGENCE TESTS; INTERVIEW, PSYCHOLOGICAL; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK;

EID: 84906939598     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.05.019     Document Type: Article

References (58)

1. Angold A., Costello E.J., Messer S.C. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int. J. Methods Psychiatr. Res. 1995, 5:237-249.
2. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
3. Blomstrom A., Karlsson H., Wicks S., Yang S., Yolken R.H., Dalman C. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring-a matched case-control study. Schizophr. Res. 2012, 140(1-3):25-30.
4. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
5. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61(8):774-780.
6. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., Perrin M., Gorman J.M., Susser E.S. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2004, 161(5):889-895.
7. Brown A.S., Schaefer C.A., Quesenberry C.P., Shen L., Susser E.S. No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia?. Am. J. Psychiatry 2006, 163(12):2178-2180.
8. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 2001, 58(11):1032-1037.
9. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav. Immun. 2001, 15(4):411-420.
10. Buka S.L., Cannon T.D., Torrey E.F., Yolken R.H. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry 2008, 63(8):809-815.
11. Classsification of occupations and coding index Office of Population Censuses and Surveys 1980, Her Majesty's Stationery Office, London, (pp. x. http://www.ons.gov.uk/ons/guide-method/classifications/archived-standard-classifications/soc-and-sec-archive/index.html).
12. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165(1):59-65.
13. David A.S., Malmberg A., Brandt L., Allebeck P., Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol. Med. 1997, 27(6):1311-1323.
14. de Graaf-Peters V.B., Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when. Early Hum. Dev. 2006, 82:257-266.
15. De Loore E., Gunther N., Drukker M., Feron F., Sabbe B., Deboutte D., van Os J., Myin-Germeys I. Persistence and outcome of auditory hallucinations in adolescence: a longitudinal general population study of 1800 individuals. Schizophr. Res. 2011, 127(1-3):252-256.
16. Delisi L.E., Smith S.B., Hamovit J.R., Maxwell M.E., Goldin L.R., Dingman C.W., Gershon E.S. Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 1986, 16(4):757-763.
17. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry 2003, 60(5):466-472.
18. Ellman L.M., Yolken R.H., Buka S.L., Torrey E.F., Cannon T.D. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol. Psychiatry 2009, 65(12):1040-1047.
19. Gold J.M., Goldberg R.W., McNary S.W., Dixon L.B., Lehman A.F. Cognitive correlates of job tenure among patients with severe mental illness. Am. J. Psychiatry 2002, 159(8):1395-1402.
20. Gotlieb-Stematsky T., Zonis J., Arlazoroff A., Mozes T., Sigal M., Szekely A.G. Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients. Arch. Virol. 1981, 67(4):333-339.
21. Hickie I.B., Banati R., Stewart C.H., Lloyd A.R. Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?. Med. J. Aust. 2009, 190(4 Suppl.):S17-S21.
22. Horwood J., Salvi G., Thomas K., Duffy L., Gunnell D., Hollis C., Lewis G., Menezes P., Thompson A., Wolke D., Zammit S., Harrison G. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br. J. Psychiatry J. Ment. Sci. 2008, 193(3):185-191.
23. 18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophr. Bull. 2013, 39(4):807-814.
24. Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994, 344(8934):1398-1402.
25. Kelleher I., Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol. Med. 2011, 41(1):1-6.
26. Khandaker G.M., Barnett J.H., White I.R., Jones P.B. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr. Res. 2011, 132(2-3):220-227.
27. Khandaker G.M., Zimbron J., Dalman C., Lewis G., Jones P.B. Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr. Res. 2012, 139(1-3):161-168.
28. Khandaker G.M., Zimbron J., Lewis G., Jones P.B. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol. Med. 2013, 43(2):239-257.
29. Khandaker G.M., Stochl J., Zammit S., Lewis G., Jones P.B. A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychol. Med. First View Article 2014, 1-10. http://dx.doi.org/10.1017/S0033291714000750. Published online: 25 April 2014.
30. Khandaker G.M., Zammit S., Lewis G., Jones P.B. A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophr. Res. 2014, 152(1):139-145.
31. Menninger K.A. Influenza and schizophrenia. An analysis of post-influenzal "dementia precox," as of 1918, and five years later further studies of the psychiatric aspects of influenza. Am. J. Psychiatry 1926, 4:469-529.
32. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90(3):285-326.
33. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
34. Mortensen P.B., Norgaard-Pedersen B., Waltoft B.L., Sorensen T.L., Hougaard D., Torrey E.F., Yolken R.H. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 2007, 61(5):688-693.
35. Mortensen P.B., Pedersen C.B., Hougaard D.M., Norgaard-Petersen B., Mors O., Borglum A.D., Yolken R.H. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr. Res. 2010, 122(1-3):257-263.
36. Murray G.K., Jones P.B. Psychotic symptoms in young people without psychotic illness: mechanisms and meaning. Br. J. Psychiatry J. Ment. Sci. 2012, 201(1):4-6.
37. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. BMJ (Clin. Res. Ed.) 1987, 295(6600):681-682.
38. Niarchou M., Zammit S., Walters J., Lewis G., Owen M.J., Bernadette van den Bree M. Defective processing speed predicts non-clinical psychotic experiences in children; longitudinal analyses in a large birth cohort. Am. J. Psychiatry 2013, 170:550-557.
39. Polanczyk G., Moffitt T.E., Arseneault L., Cannon M., Ambler A., Keefe R.S., Houts R., Odgers C.L., Caspi A. Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Arch. Gen. Psychiatry 2010, 67(4):328-338.
40. Poulton R., Caspi A., Moffitt T.E., Cannon M., Murray R., Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry 2000, 57(11):1053-1058.
41. Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., Nimgaonkar V.L. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am. J. Psychiatry 2011, 168(8):822-830.
42. Rantakallio P., Jones P., Moring J., Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int. J. Epidemiol. 1997, 26(4):837-843.
43. Rubio J.M., Sanjuan J., Florez-Salamanca L., Cuesta M.J. Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr. Res. 2012, 138(2-3):248-254.
44. Schmutzhard E. Viral infections of the CNS with special emphasis on herpes simplex infections. J. Neurol. 2001, 248(6):469-477.
45. Shaffer D., Fisher P., Lucas C.P., Dulcan M.K., Schwab-Stone M.E. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(1):28-38.
46. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747.
47. Thomas K., Harrison G., Zammit S., Lewis G., Horwood J., Heron J., Hollis C., Wolke D., Thompson A., Gunnell D. Association of measures of fetal and childhood growth with non-clinical psychotic symptoms in 12-year-olds: the ALSPAC cohort. Br. J. Psychiatry J. Ment. Sci. 2009, 194(6):521-526.
48. Torrey E.F., Leweke M.F., Schwarz M.J., Mueller N., Bachmann S., Schroeder J., Dickerson F., Yolken R.H. Cytomegalovirus and schizophrenia. CNS Drugs 2006, 20(11):879-885.
49. 11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64(9):820-822.
50. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39(2):179-195.
51. Wang H., Yolken R.H., Hoekstra P.J., Burger H., Klein H.C. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study. Schizophr. Res. 2011, 129(1):47-51.
52. Watson A.M., Prasad K.M., Klei L., Wood J.A., Yolken R.H., Gur R.C., Bradford L.D., Calkins M.E., Richard J., Edwards N., Savage R.M., Allen T.B., Kwentus J., McEvoy J.P., Santos A.B., Wiener H.W., Go R.C., Perry R.T., Nasrallah H.A., Gur R.E., Devlin B., Nimgaonkar V.L. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol. Med. 2012, 1-9.
53. Wechsler D., Golombok S., Rust J. Wechsler Intelligence Scale for Children (3rd Edition) (WISC-III UK) 1992, The Psychological Corporation.
54. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44(7):660-669.
55. WHO SCAN: Schedules for Clinical Assessment in Neuropsychiatry Version 2.0 1994, Psychiatric Publishers International/American Psychiatric Press Inc, Geneva, Switzerland.
56. Yolken R.H., Torrey E.F., Lieberman J.A., Yang S., Dickerson F.B. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr. Res. 2011, 128(1-3):61-65.
57. Zammit S., Odd D., Horwood J., Thompson A., Thomas K., Menezes P., Gunnell D., Hollis C., Wolke D., Lewis G., Harrison G. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12years in the ALSPAC birth cohort. Psychol. Med. 2009, 39(9):1457-1467.
58. Zammit S., Kounali D., Cannon M., David A.S., Gunnell D., Heron J., Jones P.B., Lewis S., Sullivan S., Wolke D., Lewis G. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am. J. Psychiatry 2013, 170(7):742-750.